- $2.59m
- $4.13m
- $2.13m
- 58
- 55
- 66
- 62
Annual balance sheet for QHSLab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.094 | 0.287 | 0.179 | 0.052 | 0.157 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.061 | 0.07 | 0.048 | 0.071 | 0.196 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.266 | 0.446 | 0.286 | 0.156 | 0.421 |
Net Intangible Assets | |||||
Total Assets | 0.298 | 2.21 | 1.96 | 1.68 | 1.8 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.215 | 0.875 | 1.71 | 2.06 | 2.41 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.906 | 1.38 | 1.88 | 2.06 | 2.41 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.608 | 0.824 | 0.076 | -0.376 | -0.608 |
Total Liabilities & Shareholders' Equity | 0.298 | 2.21 | 1.96 | 1.68 | 1.8 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |